Cervical cancer – does the morphological subtype affect survival rates?

References

• Berrington de Gonzalez A, Sweetland S, Green J. 2004. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis. British Journal of Cancer 90:1787–1791.
   PubMed Web of Science ®Google Scholar
• Boruta II DM, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE. 2001. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecologic Oncology 81:82–87.
   PubMed Web of Science ®Google Scholar
• Cancer Research UK (CRUK); [cited 2017 Jun 14]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer/survival#heading-Three
   Google Scholar
• Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, et al. 2003. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Annals of Oncology 14(Supplement 5):128–149.
   Web of Science ®Google Scholar
• Corazziari I, Quinn M, Capocaccia R. 2004. Standard cancer patient population for age standardising survival ratios. European Journal of Cancer (Oxford, England: 1990) 40:2307–2316.
   PubMed Web of Science ®Google Scholar
• Department for Communities and Local Government (DCLG). 2011. English indices of deprivation 2010; [cited 2014 Feb 11]. Available from: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2010
   Google Scholar
• Dickman PW, Adami H-O. 2006. Interpreting trends in cancer patient survival. Journal of Internal Medicine 60:103–117.
   Google Scholar
• Dickman PW, Coviello E. 2015. Estimating and modelling relative survival. The Stata Journal 15:186–215.
   Web of Science ®Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulen T. 2004. Regression models for relative survival. Statistics in Medicine 23:51–64.
   PubMed Web of Science ®Google Scholar
• Ederer F, Axtell LM, Cutler SJ. 1961. The relative survival rate: a statistical methodology. National Cancer Institute Monograph 6:101–121.
   PubMedGoogle Scholar
• Ellis-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S, et al. 2012. Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets. British Journal of Cancer 107:1220–1226.
   PubMed Web of Science ®Google Scholar
• Emmett M, Gildea C, Nordin A, Hirschowitz L, Poole J. 2017. Variations in treatment of cervical cancer according to Tumor Morphology-Population-Based Cohort Analysis of English National Cancer Registration Data. International Journal of Gynecological Cancer 27:138–146.
   PubMed Web of Science ®Google Scholar
• Esteve J, Benhamou E, Croasdale M, Raymond L. 1990. Relative survival and the estimation of net survival: elements for further discussion. Statistics in Medicine 9:529–538.
   PubMed Web of Science ®Google Scholar
• Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. 2003. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer 97:2196–2202.
   PubMed Web of Science ®Google Scholar
• Gardner GJ, Reidy-Lagunes D, Gehrig PA. 2011. Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document. Gynecologic Oncology 122:190–198.
   PubMed Web of Science ®Google Scholar
• Green J, Berrington de Gonzalez A, Sweetland S, Beral V, Chilvers C, Crossley B, et al. 2003. Risk factors for adenocarcinoma and squamous cell carcinoma of cervix in women aged 20–44 year: the UK National Case – Control Study of Cervical Cancer. British Journal of Cancer 89:2078–2086.
   PubMed Web of Science ®Google Scholar
• Hirschowitz L, Ganesan R, Singh N, McCluggage WG. 2011. Core histological data items. In: Standards and datasets for reporting cancers Dataset for histological reporting of cervical neoplasia. 3rd ed. London: The Royal College of Pathologists. p. 9.
   Google Scholar
• Intaraphet S, Kasatpibal N, Søgaard M, Khunamornpong S, Patumanond J, Chandacham A, et al. 2014. Histological type-specific prognostic factors of cervical small cell neuroendocrine carcinoma, adenocarcinoma, and squamous cell carcinoma. OncoTargets and Therapy 7:1205–1214.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer and World Health Organization (IARC/WHO). 2003. Tumours of the uterine cervix. In: Fattaneh A, Tavassoli F, Devilee P, editors. Pathology and genetics: tumours of the breast and female genital organs. World Health Organisation Classification of Tumours, Vol. 4. Lyon: IARC Press. p. 266–279.
   Google Scholar
• International Collaboration of Epidemiological Studies of Cervical Cancer (ICESCC). 2007. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. International Journal of Cancer 120:885–891.
   PubMed Web of Science ®Google Scholar
• London School of Health and Tropical Medicine (LSHTM). 2011. Life tables for England and Wales; [cited 2014 Feb 6]. Available from: http://www.csg.lshtm.ac.uk/tools-analysis
   Google Scholar
• McCluggage WG, Hirschowitz L, Ganesan R, Kehoe S, Nordin A. 2010. Which staging system to use for gynaecological cancers: a survey with recommendations for practice in the UK. Journal of Clinical Pathology 63:768–770.
   PubMed Web of Science ®Google Scholar
• McCullagh P, Nelder JA. 1989. An outline of generalized linear models. In: Generalized linear models, 2nd ed. London: Chapman & Hall/CRC Press. p. 33–36.
   Google Scholar
• McCusker ME, Coté TR, Clegg LX, Tavassoli FJ. 2003. Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecology Oncology 88:333–339.
   PubMed Web of Science ®Google Scholar
• Nasu K, Hirakawa T, Okamoto M, Nishida M, Kiyoshima C, Matsumoto H, et al. 2011. Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery. Rare Tumors 3:18–20.
   Google Scholar
• National Cancer Intelligence Network and NHS Cancer Screening Programme (NHSCSP). 2012. Profile of cervical cancer in England: incidence, mortality and survival; [cited 2014 May 06]. Available from: www.ncin.org.uk/view.?rid = 1669
   Google Scholar
• National Institute for Health and Care Excellence (NICE). 2009. Laparoscopic radical hysterectomy for early stage cervical cancer; [cited 2017 Jun 14]. Available from: https://www.nice.org.uk/guidance/IPG338
   Google Scholar
• National Institute for Health and Care Excellence (NICE). 2010. Topotecan for the treatment of recurrent and stage IVB cervical cancer; [cited 2017 Jun 14]. Available from: https://www.nice.org.uk/guidance/TA183
   Google Scholar
• National Radiotherapy Dataset (RTDS); [cited 2017 Jun 14]. Available from: http://www.ncin.org.uk/collecting_and_using_data/rtds
   Google Scholar
• NHS Cervical Screening Programme (NCIN). 2012. Audit of invasive cervical cancer: national report 2007–2011; [cited 2014 Jan 25]. Available from: http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp-audit-invasive-cervical-cancer.html
   Google Scholar
• Parkin D, Hakulinen T. 1991. Analysis of survival. Cancer registration: principles and methods. IARC Scientific publications No. 95. Lyon: International Agency for Research on Cancer (IARC). p. 159–176.
   Google Scholar
• Pecorelli S, Zigliani L, Odicino F. 2009. Revised FIGO staging for carcinoma of the cervix. International Journal of Gynaecology and Obstetrics 105:107–108.
   PubMed Web of Science ®Google Scholar
• Poole J, Bannon F, McPhail S, Barclay M, Coleman M, Emmett M, et al. 2016. Guidelines on population based cancer survival analysis. UKIACR; [cited 2016 Jan 29]. Available from: http://www.ukiacr.org/groups/analysis-group#quicktabs-analysis_group = 2
   Google Scholar
• StataCorp. 2011. Stata statistical software: release 12. College Station (TX): StataCorp LP.
   Google Scholar
• World Health Organization (WHO). 2000. Numerical lists. In: Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al., editors. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva: WHO Press. p. 45.
   Google Scholar